Medicine and Dentistry
Meta-Analysis
100%
Cervical Cancer
100%
Systematic Review
100%
microRNA
100%
Hazard Ratio
45%
Cancer Tissue
18%
Malignant Neoplasm
9%
Diagnosis
9%
Survival Rate
9%
Biological Marker
9%
down Regulation
9%
Personalized Medicine
9%
Random Effects Model
9%
Overall Survival
9%
Case-Control Study
9%
microRNA 155
9%
INIS
cancer
100%
reviews
100%
hazards
83%
tissues
33%
control
16%
therapy
16%
medicine
16%
values
16%
guidelines
16%
biological markers
16%
randomness
16%
Immunology and Microbiology
Cancer Tissue
100%
Survival Rate
50%
down Regulation
50%
Overall Survival
50%
Prognostic Biomarker
50%
Pharmacology, Toxicology and Pharmaceutical Science
Uterine Cervix Cancer
100%
microRNA
100%
Case-Control Study
9%
Random Effects Model
9%
Malignant Neoplasm
9%
Biological Marker
9%
Survival Rate
9%
Overall Survival
9%
microRNA 155
9%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Case-Control Study
9%
down Regulation
9%
Survival Rate
9%
Overall Survival
9%
MiR-155
9%